Flash Glucose Evaluation

Aim:

This study aims to generate evidence supporting the effective implementation of continuous glucose monitoring (CGM) as a supplement to face-to-face care for Aboriginal and Torres Strait Islander people with type 2 diabetes.
Healthcare providers will be invited to participate in a 30-minute interview, conducted in person or remotely, to explore the barriers and enablers to using CGM and potential pathways to overcome these barriers.
Participants will be reimbursed for their time. No additional onsite visits are required.

Audience:

• Aboriginal and Torres Strait Islander people with type 2 diabetes.
• Health professionals experienced in providing care for Aboriginal and Torres Strait Islander people with type 2 diabetes who have or are using continuous flash glucose monitors.

Benefits:

This study is important because research has shown that the effectiveness of an intervention (such as CGM) does not always lead to its widespread adoption of the intervention. Identifying barriers and enablers to using continuous glucose monitoring will contribute to improving healthcare access, equity, and health outcomes for Aboriginal and Torres Strait Islander people with type 2 diabetes.

Site location (for participants):

Online interview (by Zoom, Teams, or phone call)

For further information please follow these links to:

• Participant information and Consent Form.

This study has received ethical approval from the St Vincent’s Hospital (Melbourne) Human Research Ethics Committee (HREC 188/20)